PharmaCyte Biotech (PMCB): SEC Form 3: New insider Schechter Jonathan claimed ownership of 50,000 shares
Stocks in this Quantisnow insightHealth Care
Keep researching PMCB
- PMCB insider tradesEvery buy and sale reported by PharmaCyte Biotech Inc. officers, directors and large holders.
- What is Form 3?The initial SEC statement of beneficial ownership filed by a company's officers, directors and 10% holders when they first become insiders.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- PMCB financial statementsRevenue, profit, cash flow and balance sheet from PharmaCyte Biotech Inc.'s SEC filings.
Quantisnow market dataNASDAQ
PMCB
PharmaCyte Biotech Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
Get push alerts for PMCB
Full PMCB profile on Quantisnow Follow PMCB and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time